The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 05, 2021
Filed:
Mar. 02, 2017
Applicant:
Teva Pharmaceutical Industries Ltd., Petach Tikva, IL;
Inventor:
Prakash Sundaramurthi, Fort Washington, PA (US);
Assignee:
Teva Pharmaceutical Industries Ltd., Petach Tikva, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/57 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 9/10 (2006.01); A61K 47/18 (2017.01); A61K 31/225 (2006.01); A61P 29/02 (2006.01); A61P 15/18 (2006.01); A61P 35/00 (2006.01); A61K 47/02 (2006.01); A61K 47/14 (2017.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 9/10 (2013.01); A61K 31/225 (2013.01); A61K 31/57 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61P 15/18 (2018.01); A61P 29/02 (2018.01); A61P 35/00 (2018.01);
Abstract
The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 360 mg/ml to 440 mg/ml medroxyprogesterone acetate, 1.35 mg/ml to 1.65 mg/ml docusate sodium, polyethylene glycol, and water. Methods of using these compositions are also described.